Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Neuroscience Research Australia
Randwick, New South Wales, Australia
- Mental Health Research Institute
Melbourne, Victoria, Australia
- the Mccuster Foundation of Alzheimer'S Disease Research
Nedlands, Western Australia, Australia
- Chu de Toulouse - Hôpital Purpan
Toulouse, Haute Garonne, France
- Groupe Hospitalier Pitie-Salpetriere
Paris, Paris, France
- Chu de Rouen - Hôpital Charles Nicolle
Rouen, Seine Maritime, France
- University of Puerto Rico, School of Medicine
San Juan, Puerto Rico
- Hospital Clínic I Provincial de Barcelona
Barcelona, Spain
- the National Hospital for Neurology and Neurosurgery
London, Greater London, United Kingdom
- University of Alabama in Birmingham
Birmingham, Alabama, United States
- University of California San Diego Medical Center
La Jolla, California, United States
- Emory University
Atlanta, Georgia, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Butler Hospital
Providence, Rhode Island, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2020
- Primary completion
- 6 Oct 2023
- Completion
- 13 Nov 2023
- Last update posted
- 4 Feb 2025
- Registered enrollment
- 73
- Registry id
- NCT06424236
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.